| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.42 | 0.007 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |